104 related articles for article (PubMed ID: 36915000)
1. Tumor Necrosis Is an Indicator of Poor Prognosis Among Hepatoma Patients Undergoing Resection.
Kuo FY; Eng HL; Li WF; Liu YW; Wang CC; Lin CC; Yong CC; Yen YH
J Surg Res; 2023 Mar; 283():1091-1099. PubMed ID: 36915000
[TBL] [Abstract][Full Text] [Related]
2. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
[No Abstract] [Full Text] [Related]
3. Microscopic vascular invasion may not be associated with survival of patients undergoing resection for solitary hepatoma of ≤ 2 cm.
Li WF; Liu YW; Wang CC; Yong CC; Lin CC; Yen YH
PLoS One; 2023; 18(2):e0281154. PubMed ID: 36758025
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis as a poor prognostic predictor on postoperative survival of patients with solitary small hepatocellular carcinoma.
Ling YH; Chen JW; Wen SH; Huang CY; Li P; Lu LH; Mei J; Li SH; Wei W; Cai MY; Guo RP
BMC Cancer; 2020 Jun; 20(1):607. PubMed ID: 32600297
[TBL] [Abstract][Full Text] [Related]
5. Association of Preoperative Hypercoagulability with Poor Prognosis in Hepatocellular Carcinoma Patients with Microvascular Invasion After Liver Resection: A Multicenter Study.
Zhang XP; Zhou TF; Wang ZH; Zhang F; Zhong CQ; Hu YR; Wang K; Chai ZT; Chen ZH; Wu MC; Lau WY; Cheng SQ
Ann Surg Oncol; 2019 Nov; 26(12):4117-4125. PubMed ID: 31321582
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
[TBL] [Abstract][Full Text] [Related]
7. Huge hepatocellular carcinoma greater than 10 cm in diameter worsens prognosis by causing distant recurrence after curative resection.
Wakayama K; Kamiyama T; Yokoo H; Orimo T; Shimada S; Einama T; Kamachi H; Taketomi A
J Surg Oncol; 2017 Mar; 115(3):324-329. PubMed ID: 28192617
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis as a predictor of early tumor recurrence after resection in patients with hepatoma.
Yen YH; Kuo FY; Eng HL; Liu YW; Yong CC; Li WF; Wang CC; Lin CY
PLoS One; 2023; 18(11):e0292144. PubMed ID: 37972101
[TBL] [Abstract][Full Text] [Related]
9. The risk factors for long-term survival outcome in solitary hepatocellular carcinoma up to 2 cm: Propensity score matching analysis in a population cohort with a high rate of HBV infection.
Wang G; Zhang W; Tan Y; Jiang L; Yang J; Yang J; Yan L
Int J Surg; 2019 Dec; 72():1-6. PubMed ID: 31610283
[TBL] [Abstract][Full Text] [Related]
10. Association of type 2 diabetes mellitus with incidences of microvascular invasion and survival outcomes in hepatitis B virus-related hepatocellular carcinoma after liver resection: A multicenter study.
Zhang XP; Chai ZT; Feng JK; Zhu HM; Zhang F; Hu YR; Zhong CQ; Chen ZH; Wang K; Shi J; Guo WX; Chen CS; Wu MC; Lau WY; Cheng SQ
Eur J Surg Oncol; 2022 Jan; 48(1):142-149. PubMed ID: 34452770
[TBL] [Abstract][Full Text] [Related]
11. Liver resection of hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guideline recommendations: Results from a high-volume liver surgery center in East Asia.
Liu YW; Yong CC; Lin CC; Wang CC; Chen CL; Cheng YF; Wang JH; Yen YH; Chen CH
J Surg Oncol; 2020 Dec; 122(8):1587-1594. PubMed ID: 32815189
[TBL] [Abstract][Full Text] [Related]
12. Outcomes Following Resection of Hepatocellular Carcinoma in the Absence of Cirrhosis.
Lewis RH; Glazer ES; Bittenbinder DM; O'Brien T; Deneve JL; Shibata D; Behrman SW; Vanatta JM; Satapathy SK; Dickson PV
J Gastrointest Cancer; 2019 Dec; 50(4):808-815. PubMed ID: 30117090
[TBL] [Abstract][Full Text] [Related]
13. Importance of tumor size as a prognostic factor after partial liver resection for solitary hepatocellular carcinoma: Implications on the current AJCC staging system.
Goh BK; Teo JY; Chan CY; Lee SY; Jeyaraj P; Cheow PC; Chow PK; Ooi LL; Chung AY
J Surg Oncol; 2016 Jan; 113(1):89-93. PubMed ID: 26611492
[TBL] [Abstract][Full Text] [Related]
14. Resection or transplantation for early hepatocellular carcinoma in a cirrhotic liver: does size define the best oncological strategy?
Adam R; Bhangui P; Vibert E; Azoulay D; Pelletier G; Duclos-Vallée JC; Samuel D; Guettier C; Castaing D
Ann Surg; 2012 Dec; 256(6):883-91. PubMed ID: 23108125
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Liver Transplantation and Liver Resection for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus Type I and Type II.
Lv JY; Zhang NN; Du YW; Wu Y; Song TQ; Zhang YM; Qu Y; Liu YX; Gu J; Wang ZY; Qiu YB; Yang B; Tian DZ; Guo QJ; Zhang L; Sun JS; Xie Y; Wang ZL; Sun X; Jiang WT; Lu W
Yonsei Med J; 2021 Jan; 62(1):29-40. PubMed ID: 33381932
[TBL] [Abstract][Full Text] [Related]
16. Serosal invasion strongly associated with recurrence after curative hepatic resection of hepatocellular carcinoma: a retrospective study of 214 consecutive cases.
Sonohara F; Nomoto S; Inokawa Y; Kanda M; Yamada S; Fujii T; Sugimoto H; Kodera Y
Medicine (Baltimore); 2015 Mar; 94(9):e602. PubMed ID: 25738484
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent.
Lurje G; Bednarsch J; Czigany Z; Amygdalos I; Meister F; Schöning W; Ulmer TF; Foerster M; Dejong C; Neumann UP
Langenbecks Arch Surg; 2018 Nov; 403(7):851-861. PubMed ID: 30267147
[TBL] [Abstract][Full Text] [Related]
18. Nomogram for preoperative estimation of long-term survival of patients who underwent curative resection with hepatocellular carcinoma beyond Barcelona clinic liver cancer stage A1.
Ruan DY; Lin ZX; Wang TT; Zhao H; Wu DH; Chen J; Dong M; Lin Q; Wu XY; Li Y
Oncotarget; 2016 Sep; 7(38):61378-61389. PubMed ID: 27542216
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the American Joint Committee on Cancer (AJCC) 8th Edition Staging System for Hepatocellular Carcinoma in 1,008 Patients with Curative Resection.
Park S; Choi S; Cho YA; Sinn DH; Kim JM; Park CK; Ha SY
Cancer Res Treat; 2020 Oct; 52(4):1145-1152. PubMed ID: 32599989
[TBL] [Abstract][Full Text] [Related]
20. Tumor Necrosis Impacts Prognosis of Patients Undergoing Curative-Intent Hepatocellular Carcinoma.
Wei T; Zhang XF; Bagante F; Ratti F; Marques HP; Silva S; Soubrane O; Lam V; Poultsides GA; Popescu I; Grigorie R; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
Ann Surg Oncol; 2021 Feb; 28(2):797-805. PubMed ID: 33249525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]